Traders Purchase Large Volume of Put Options on ResMed (RMD)
Shares of ResMed (NYSE:RMD) was the recipient of some unusual options trading activity on Friday. Stock investors purchased 12,526 put options on the company, American Banking News.com reports. This is an increase of approximately 433% compared to the average daily volume of 2,352 put options.
A number of analysts have recently weighed in on RMD shares. Analysts at UBS AG upgraded shares of ResMed from a “neutral” rating to a “buy” rating in a research note to investors on Friday. Separately, analysts at Deutsche Bank downgraded shares of ResMed from a “buy” rating to a “hold” rating in a research note to investors on Friday. They now have a $54.00 price target on the stock, down previously from $58.00. Finally, analysts at Piper Jaffray Cos. raised their price target on shares of ResMed from $54.00 to $59.00 in a research note to investors on Wednesday, October 9th. Nine investment analysts have rated the stock with a hold rating and seven have given a buy rating to the company. ResMed currently has a consensus rating of “Hold” and a consensus target price of $48.93.
Shares of ResMed (NYSE:RMD) traded down 12.00% during mid-day trading on Friday, hitting $49.55. 6,832,270 shares of the company’s stock traded hands. ResMed has a 52 week low of $37.31 and a 52 week high of $52.77. The stock’s 50-day moving average is $48.96 and its 200-day moving average is $46.95. The company has a market cap of $7.039 billion and a P/E ratio of 26.81.
ResMed (NYSE:RMD) last released its earnings data on Thursday, October 24th. The company reported $0.56 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.58 by $0.02. The company had revenue of $357.66 million for the quarter, compared to the consensus estimate of $372.28 million. During the same quarter in the previous year, the company posted $0.49 earnings per share. The company’s revenue for the quarter was up 5.3% on a year-over-year basis.
The company also recently announced a quarterly dividend, which is scheduled for Wednesday, December 18th. Shareholders of record on Tuesday, November 19th will be paid a dividend of $0.25 per share. This represents a $1.00 annualized dividend and a dividend yield of 2.02%. The ex-dividend date is Friday, November 15th.
ResMed Inc, (NYSE:RMD) is a holding company for the ResMed Group.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.